市场调查报告书
商品编码
1166511
2022-2029 年载玻片染色机的全球市场Global Slide Stainer Market - 2022-2029 |
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
到 2021 年,载玻片染色机的全球市场规模将达到 37.042 亿美元,并且在预测期间(2022-2029 年)的复合年增长率为 11%。
染色剂用于分离组织和细胞以进行显微镜检查和鑑定。 载玻片染色机通过直接染色、间接染色、表面吸附染色和媒染染色将染料扩散到标本中,从而自动对製备好的细胞学和组织学标本进行染色。 全自动染色机有旋转输送和直线输送两种工艺。
全球载玻片染色机市场的增长受到慢性病和传染病患病率上升的推动,技术进步以及对诊断和临床研究自动化需求的增长是推动市场增长的关键因素。
慢性病患病率上升预计将推动预测期内的增长
慢性和危及生命的疾病数量不断增加,这促使製药和研究公司将研发工作重点放在开发有效的治疗方法上。 实验室仪器自动化的进步导致载玻片染色机被应用于疾病诊断和肿瘤研究。
根据国际糖尿病联合会的数据,2019 年糖尿病患者花费了 7600 亿美元,其中大部分花在了 1 型糖尿病患者的胰岛素上。 目前,约有 4.63 亿成年人(20-79 岁)患有糖尿病,预计到 2045 年将增加到 7 亿。 在大多数国家,2 型糖尿病患者的比例都在增加。 此外,据美国心臟协会称,2015 年约有 41.5% 的美国人口患有某种形式的心脏病,预计到 2035 年这一患病率将增加到 45%。 根据美国疾病控制和预防中心 (CDC) 的数据,大约一半 (47%) 的美国人口至少具有这三种风险因素中的一种。 根据美国国家癌症研究所的数据,最常见的癌症是前列腺癌、乳腺癌、肺癌和支气管癌、结直肠癌、皮肤黑色素瘤、膀胱癌、非霍奇金淋巴瘤、肾癌和肾盂癌、子宫内膜癌、白血病、胰腺癌、甲状腺癌和肝癌。
因此,慢性病和传染病引起的日益严重的健康危害是推动载玻片染色机需求的主要因素,尤其是在发达国家。 在新兴国家,传染病的流行正在增加常规体检的公共支出,促使医院和其他医疗保健提供者实现实验室流程自动化。 因此,对高性能载玻片染色机的需求正在增加。
与自动载玻片染色机相关的担忧可能会阻碍市场增长
使用自动染色机存在一些问题,例如初始成本、空间可用性和维修问题,这些问题减缓了载玻片染色机的采用。 常规染色机可能只有手动方法作为备用,或者染色机可能占据实验室中唯一适合手动染色系统的空间。
对于发展中国家缺乏专业知识的服务技术人员来说,停机维修时间更长。 一些工程师反对仅限于某些系统所需的专有试剂。
另一个问题是实验室技术人员离开了染色过程。 手工染色时,技术人员可以观察每个步骤。 如果您觉得有什么地方不对劲,您通常可以停止程序并解决问题。
自动化系统中的染色问题在此阶段很难排除,因为在看到成品之前可能不会注意到染色问题。 在培训环境中,学习染色原理很重要,但用机器代替人眼和手可能会损害您理解实际染色过程的能力。
全球载玻片染色机市场根据波特五力分析、供应链分析、监管分析、定价分析、报销分析和未满足需求等各种行业因素对市场进行了深入分析。
COVID-19 影响分析
COVID-19 大流行每天都在继续蔓延,严重影响着人们、社区和企业。 在对某些行业的增长产生重大影响的同时,许多其他市场可能保持完好并提供有希望的增长机会。 全球载玻片染色机市场从 COVID-19 流行病中看到了巨大的推动力,因为利益相关者越来越多地寻找诊断和治疗感染 COVID-19 患者的新方法。
一些製药和生物技术公司正在加大研发力度。 因此,预计对临床研究的需求增加将为载玻片染色机製造商带来一些机会,从而有望在预测期内推动市场增长。 新型冠状病毒的急剧爆发正在影响全球的生活。 医院和实验室需要获得可靠的 COVID-19 测试套件,并且已经出现了几家公司来帮助一线医疗专业人员抗击 COVID-19 的传播。 诊断或分子测试可以回答一个人是否感染了活跃的 SARS-CoV-2。 另一方面,血清学和抗体测试通过在一个人的血液中寻找 COVID-19 抗体来揭示一个人是否感染了 COVID-19。 超过 100 项 COVID-19 诊断测试已获得紧急使用授权 (EUA)。
The global slide stainer market size was valued at US$ 3704.2 million in 2021 and is estimated to reach US$ YY million by 2029, growing at a CAGR of 11% during the forecast period (2022-2029).
A stainer is used to separate tissues or cells, to carry microscopic study and identification. A slide stainer automates the staining of prepared cytology or histology tissue specimens by diffusing dyes into the samples through direct or indirect staining, surface adsorption, or mordant staining. An automated slide stainer uses two processes, rotating transport and linear transport.
The global slide stainer market growth is driven rising prevalence of chronic and infectious diseases, technological advancements, and growing demand for automation in diagnostics and clinical research are among the key factors driving the market growth.
The increasing prevalence of chronic diseases is expected to drive growth in the forecast period
The growing prevalence of chronic and life-threatening diseases is driving pharmaceutical companies and research firms to focus on R&D activities to develop effective therapeutics. Strides made in lab instrumentation automation have led to the application of slide stainers in disease diagnosis and oncology research.
As per the International Diabetes Federation, diabetes patients spent US$ 760 billion in 2019, of which, most was spent by Type-1 diabetes patients on insulin drugs. Around 463 million adults (20-79 years) are living with diabetes currently, and by 2045 this is projected to rise to 700 million. The proportion of type 2 diabetes people is increasing in most countries. Also, as per the American Heart Association, in 2015, approximately 41.5% of the U.S. population was suffering from some form of cardiac disease, it is further estimated that this prevalence is likely to increase to 45% by 2035. According to the Centers for Disease Control and Prevention (CDC) of the U.S., about half of the population (47%) of the United States have at least one of these three risk factors. According to the National Cancer Institute, the most common cancers are prostate cancer, breast cancer, lung and bronchus cancer, colon and rectum cancer, melanoma of the skin, bladder cancer, non-Hodgkin lymphoma, kidney and renal pelvis cancer, endometrial cancer, leukemia, pancreatic cancer, thyroid cancer, and liver cancer.
Hence, the growing health burden of chronic and infectious diseases is a major factor boosting the demand for slide stainers, especially in developed countries. In developing countries, the prevalence of infectious diseases has increased the spending of the population on regular health checkups, which has encouraged healthcare providers such as hospitals to automate lab processes. This has increased the demand for high-performing slide stainers.
Concerns associated with automated slide stainers are likely to hinder market growth
There are some concerns associated with the use of autostainers such as the initial expense, space availability, and repair issues, which are slow the adoption of slide stainers. A routine stainer may have only a manual method as a backup, but the stainer may be occupying the only space in the laboratory where a manual stain system can fit.
The downtime for repairs is lengthy if service technicians with lack of professional technicians in developing countries. Some technologists object to being limited to the dedicated reagents required by some systems.
Another concern is that the technologist is now removed from the staining process. When doing a manual stain, the technologist can observe each step; if he or she sees that something is wrong, the procedure can often be stopped to correct the problem.
A staining problem on an automated system may not be noticed until the finished product is reviewed, and sometimes troubleshooting at this stage is difficult. In training situations, learning the principles of staining is important, and the use of a machine instead of human eyes and hands may impair the trainee's ability to understand the actual process of staining.
The global slide stainer market provides in-depth analysis of the market based on various industry factors such as porter's five force analysis, supply chain analysis, regulatory analysis, pricing analysis, reimbursement analysis, unmet needs.
COVID-19 Impact Analysis
The COVID-19 pandemic continues to unfold everyday with severe impact on people, communities, and businesses. The growth in several industries are impacted significantly while numerous other markets may remain unscathed and show promising growth opportunities. The global slide stainer market has received immense impetus from the COVID-19 pandemic, as stakeholders are increasingly searching for newer approaches towards diagnosing and curing patients affected by the COVID-19.
Increasing research and development is being undertaken by several pharmaceutical and biotechnology companies. Thus, rising demand for clinical research is expected to generate several opportunities for the slide stainer manufacturers, hence, expected to boost the market growth over the forecast period. The dramatic explosion of the novel coronavirus is affecting lives globally. Hospitals and labs need access to reliable COVID-19 test kits, and several companies are coming up to support the medical professionals on the front lines working to prevent the spread of COVID-19. Diagnostic or molecular tests answer whether a person has active SARS-CoV-2 infection or not. In contrast, serological or antibody tests reveal if a person had COVID-19 by assaying for the presence of antibodies to COVID-19 in a person's blood. Over 100 COVID-19 diagnostic tests with Emergency Use Authorization (EUA).
The hematoxylin and eosin segment is expected to grow at the fastest CAGR during the forecast period (2022-2029)
Hematoxylin and Eosin have been used for recognizing various tissue types and morphologic changes. Hematoxylin has deep blue to purple color and stain nuclei of the cells, against pink background counterstained by Eosin. Moreover, hematoxylin and eosin are the key ingredients in stains used by biological laboratories and pathologists. Hematoxylin is an excellent nuclear stain that is used widely in cytology and histology, two of the most important uses being as a nuclear stain in the Papanicolaou procedure for the diagnosis of vaginal cancer and in combination with the contrast stain Eosin, which is the chief diagnostic tool for most other cancers.
Rising demand for the hematoxylin and eosin for the various diagnostic test and laboratories uses is expected to fuel the growth of the segment over the forecast period. Moreover, increasing technological development such as the expansion of high throughput hematology analyzers and the introduction of basic cytometry techniques analyzers have been propelling segment growth and the trend is expected to continue over the forecast period.
However, intense competition among existing players and the high cost of hematoxylin and eosin are supposed to restrain the market in the forecast period. Also, time-consuming and stringent regulatory policies are projected to hamper market growth over the forecast period.
North America region holds the largest market share of the global slide stainer market
North America is anticipated to account for a major share of the global slide stainer market. This can be ascribed to the region leading in a wide array of diagnostic and research capabilities and in the adoption of automation for the same. Histological and cytological examinations are a routine part of diagnostics and drug discovery research, an arena in which North America are frontrunners. Key players operating in the global slide stainer market in the region are collaborating, partnership, acquisition and product launch, that will drive the growth of the market in the region.
For instance, in February 13, 2020, Biocare Medical LLC Launch of seven novel IVD IHC antibody markers for clinical diagnostics and research applications. The most recent launch focuses on several immuno-oncology markers, critical in aiding early-stage cancer drug developments and patient treatment.
Also, in the USA, favorable national regulatory mechanisms along with presence of large patient pool further accelerates overall business growth. Moreover, increasing use of dignostic services with enhanced support for research and ethics augments the demand for slide stainer in the region.
The slide stainer market is moderately competitive with the presence of local as well as global companies. Some of the key players which are contributing to the growth of the market include Agilent Technologies Inc., Danaher Corp., Sakura, BioGenex, Thermo Fisher Scientific, Biocare Medical, Merck Group, General Data Company, and Hardy Diagnostics, among others. The major players are adopting several growth strategies such as product launches, acquisitions, and collaborations, which are contributing to the growth of the slide stainer market globally. For instance, in March 2020, ELITechGroup Inc. launched the Aerospray Cytology Slide Stainer Cytocentrifuge which automates the preparation and staining of liquid-based cytology specimens to facilitate the examination of an array of cell differentiations utilizing Papanicolaou staining techniques. The device performs two functions of sample preparation through cytocentrifugation and sample staining.
Sakura Finetek
Overview: Sakura Finetek, was founded in 1986 with the U.S. office based in Torrance, California. It is the global leader in continuous innovation for pathology by providing integrated solutions for anatomic pathology and patients through best-in-class innovation, quality, and customer care. Sakura Finetek is a leading industry in the development and commercialization of automated histology instrumentation and consumables for anatomic pathology. The company specializes in pathology, histology, smart automation, tissue processors, tissue embedders, H&E stainers, cover slippers - film & glass, advanced staining - IHC & ISH, microtomes, cassette & slide printers, blades, grossing, storage systems - blocks & slides, cryostats, digital microscopes, histopathology, cancer diagnostics, tissue-Tek, accu-edge, and histology consumables
Product Portfolio: Histo-Tek SL Slide Stainer: The Histo-Tek SL Slide Stainer is an automated slide stainer offering a new level of convenience and standardization for your low-volume laboratory needs, all at a low total cost of ownership.
The global slide stainer market report would provide an access to an approx. 40+ market data table, 45+ figures and 180 pages.
LIST NOT EXHAUSTIVE